Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,600 | 2 | 76.5% |
| Food and Beverage | $853.13 | 6 | 11.7% |
| Travel and Lodging | $786.55 | 3 | 10.7% |
| Education | $80.56 | 6 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | $3,260 | 3 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,400 | 1 | $0 (2021) |
| BioMarin Pharmaceutical Inc. | $1,465 | 7 | $0 (2019) |
| GENZYME CORPORATION | $174.64 | 2 | $0 (2024) |
| Retrophin, Inc. | $20.56 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $129.64 | 1 | GENZYME CORPORATION ($129.64) |
| 2021 | $2,430 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($2,400) |
| 2020 | $3,230 | 2 | Ultragenyx Pharmaceutical Inc. ($3,230) |
| 2019 | $1,459 | 10 | BioMarin Pharmaceutical Inc. ($1,394) |
| 2018 | $71.14 | 2 | BioMarin Pharmaceutical Inc. ($71.14) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2024 | GENZYME CORPORATION | CERDELGA (Drug), CEREZYME | Food and Beverage | In-kind items and services | $129.64 | General |
| Category: Genetic Disease | ||||||
| 08/09/2021 | Ultragenyx Pharmaceutical Inc. | — | Education | In-kind items and services | $30.00 | General |
| 04/07/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 12/09/2020 | Ultragenyx Pharmaceutical Inc. | DOJOLVI (Drug) | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| Category: Oral nutritional supplements | ||||||
| 09/25/2020 | Ultragenyx Pharmaceutical Inc. | DOJOLVI (Drug) | Education | In-kind items and services | $30.00 | General |
| Category: Oral nutritional supplements | ||||||
| 11/16/2019 | BioMarin Pharmaceutical Inc. | — | Food and Beverage | Cash or cash equivalent | $585.33 | General |
| 11/16/2019 | BioMarin Pharmaceutical Inc. | — | Travel and Lodging | Cash or cash equivalent | $393.20 | General |
| 11/16/2019 | BioMarin Pharmaceutical Inc. | — | Travel and Lodging | Cash or cash equivalent | $321.97 | General |
| 11/16/2019 | BioMarin Pharmaceutical Inc. | — | Travel and Lodging | Cash or cash equivalent | $71.38 | General |
| 10/05/2019 | BioMarin Pharmaceutical Inc. | Palynziq (Drug), Kuvan | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: PKU | ||||||
| 05/17/2019 | GENZYME CORPORATION | DISEASE STATE (Drug) | Food and Beverage | In-kind items and services | $45.00 | General |
| 02/07/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $10.12 | General |
| Category: Hepatology | ||||||
| 02/07/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $7.38 | General |
| Category: Hepatology | ||||||
| 02/07/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $1.89 | General |
| Category: Hepatology | ||||||
| 02/07/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $1.17 | General |
| Category: Hepatology | ||||||
| 12/06/2018 | BioMarin Pharmaceutical Inc. | Kuvan (Drug), Palynziq | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: PKU | ||||||
| 04/10/2018 | BioMarin Pharmaceutical Inc. | Kuvan (Drug), BMN 165 | Food and Beverage | In-kind items and services | $41.27 | General |
| Category: PKU | ||||||
About Dr. Peter Baker, MD
Dr. Peter Baker, MD is a Pediatrics healthcare provider based in Aurora, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1295946176.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Baker, MD has received a total of $7,320 in payments from pharmaceutical and medical device companies, with $129.64 received in 2024. These payments were reported across 17 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($5,600).
Practice Information
- Specialty Pediatrics
- Other Specialties Clinical Genetics (M.D.)
- Location Aurora, CO
- Active Since 05/24/2007
- Last Updated 06/20/2024
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1295946176
Products in Payments
- DOJOLVI (Drug) $3,230
- CERDELGA (Drug) $129.64
- Kuvan (Drug) $71.14
- DISEASE STATE (Drug) $45.00
- Palynziq (Drug) $22.02
- (820) Cholbam (Drug) $20.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Aurora
Natalie Nokoff, Md, MD
Pediatrics — Payments: $152,727
Dr. Matthew Greenhawt, Md, Mba, MD, MBA
Pediatrics — Payments: $120,823
Stephen Daniels, Md, Phd, MD, PHD
Pediatrics — Payments: $85,612
Michael Verneris, Md, MD
Pediatrics — Payments: $84,569
Amanda Dempsey, Md Phd, MD PHD
Pediatrics — Payments: $78,729
Dustin Nash, Md, MD
Pediatrics — Payments: $29,628